Phase 2: Entecavir Tab 1 mg (Bristol Myers Squibb Company, USA)

2 trials

Sponsors

Institute of Clinical Pharmacy, Central South University, Chinese PLA General Hospital

Conditions

Bioequivalence Study in humanPharmacokinetics and Bioequivalence Study in human

Phase 1

Bioequivalence of Entecavir Tablets (Fasting) in the Human Body

RecruitingChiCTR-IIR-17010480

Institute of Clinical Pharmacy, Central South UniversityPharmacokinetics and Bioequivalence Study in human

Start: 2017-01-23Updated: 2017-04-18

Two-treatment, two-cycle, two-period, open, randomized crossover in-vivo bioequivalence study of entecavir tablets

RecruitingChiCTR-IIR-17011142

Chinese PLA General HospitalBioequivalence Study in human

Start: 2017-04-12Updated: 2017-04-18